查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1403336

全球毒理學測試市場預測（-2030）：按產品、測試類型、方法、技術、最終用戶和地區進行分析

Toxicology Testing Market Forecasts to 2030 - Global Analysis By Product, Test Type, Method, Technology, End User and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

預測期內，全球毒性測試市場規模將以 15.9% 的複合年成長率成長。

毒理學測試涉及評估物質對生物體的影響，以評估對人類健康或環境的潛在危害。確定與化學品、藥品、消費品和環境污染物相關的安全性、毒性和風險。其重要性在於透過識別和減輕風險、支持監管合規性以及指南產品開發來保護公眾健康。

根據 NCBI 的數據，在發現階段合成的每 10,000 種化合物中，只有 250 種達到臨床前階段，並且有一種藥物最終獲得 FDA核准。

增加研發活動

製藥、生物技術和化學製造等行業不斷尋找新的化合物、配方和產品。毒理學測試在這些領域發揮著至關重要的作用，在這些創新技術引入市場之前對其安全性、有效性和潛在風險進行評估。此外，強大的毒性評估可確保符合監管標準，並有助於減少對人類健康和環境的不利影響。隨著消費者需求的變化和技術突破，研發工作不斷增加，徹底的毒性測試的需求也在增加，這對於新藥、化學品和產品的創造和核准至關重要。

資料解釋的複雜性

許多實驗和最尖端科技產生的複雜多樣的資料使得分析具有挑戰性，並且難以轉化為有用的見解。準確評估這種複雜性需要特定的知識、先進的設備和標準化的框架。解釋此類複雜統計資料時的錯誤和不確定性可能會損害風險評估、監管備案和產品開發中的決策，並可能阻礙市場核准和開發。

對替代測試方法的需求不斷成長

試管內測定、類器官、微流體系統和計算模型等先進技術為毒性評估提供了有前途的替代方案，提供更準確、更具成本效益和道德的測試工具。投資研發以檢驗這些替代品並將其商業化的公司將能夠利用這種不斷成長的需求。此外，這些替代品的廣泛採用將簡化測試過程並提供更快的結果，這符合更人性化和可預測的毒性評估的全球趨勢。這樣，就成為了市場拓展的動力。

監管變化

不斷發展和收緊的安全評估法規會影響測試方法、驗證要求和產品核可時間表，需要不斷調整和遵守。監管標準的突然變化或新指南的引入可能會導致不確定性、成本增加和核准過程的延遲。如果無法快速回應新標準，可能會導致違規處罰、競爭力下降和市場准入減少，從而使毒理學測試市場難以保持效率並應對不斷變化的要求，這給企業帶來了挑戰。

COVID-19 的影響

由於業務關閉和研究影響，COVID-19 爆發最初導致資源重新轉向與大流行相關的研究。測試和監管流程繼續延遲，導致產品核准延遲。然而，這場危機凸顯並提高了毒性測試在疫苗開發和藥物安全評估中的重要性。業界以遠距工作和虛擬考試作為回應，刺激了創新和數位化。對安全評估意識的提高導致人們重新重視穩健的調查方法，為疫情後的恢復鋪路。

遺傳毒性測試部分預計將在預測期內成為最大的部分

遺傳毒性測試部分估計佔最大佔有率。遺傳毒性測試採用評估物質誘導突變、染色體畸變和 DNA 損傷的能力的分析方法，對於識別潛在的致癌物質和有害化合物至關重要。這些試驗包括Ames試驗、微核試驗、彗星試驗等體外及體內方法，綜合分析遺傳毒性。此外，了解基因毒性有助於確定藥物、化學物質、農藥和消費品的安全性，並為監管評估做出巨大貢獻，以確保人類健康和環境免受有害的基因變化的影響。

體內測試領域預計在預測期內複合年成長率最高。

預計體內測試領域在預測期內將出現良好的成長。體內測試是對整個活體（例如植物或動物）進行的實驗類型。它有助於確定毒性水平、不良反應和潛在的健康危害，為監管和安全評估提供關鍵資料。此外，儘管存在倫理方面的考慮，這些測試對於全面了解物質的生物效應並確保保護人類健康和環境免受潛在有害化合物的侵害至關重要。

比最大的地區

由於工業化程度不斷提高、監管指南更加嚴格以及環境安全意識不斷增強，亞太地區在預測期內佔據了最大的市場佔有率。技術進步、製藥和生物技術領域的擴張以及化妝品和食品行業對毒性評估的需求正在推動市場擴張。此外，中國、印度、日本和韓國等國家正在透過擴大經濟和擴大研究舉措做出重要貢獻。推動該市場成長的是對產品安全評估的重視以及對可靠毒性測試方法的需求。

複合年成長率最高的地區：

由於嚴格的法律規範、對產品安全的日益關注和技術進步，預計北美在預測期內將實現盈利成長。該地區擁有成熟的製藥和生物技術產業，研發活動不斷增加，因此市場預計將擴大。此外，對化學品暴露的日益關注以及醫療、化妝品和環境監測等各個領域對有效毒性評估的需求正在推動市場成長。美國和加拿大等主要貢獻國家見證了測試方法的不斷進步，推動了創新和市場滲透。

免費客製化服務：

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 產品分析
  • 技術分析
  • 最終用戶分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章全球毒理學測試市場：按產品

  • 裝置
  • 試劑和套件
  • 其他產品

第6章全球毒理學測試市場：依測試類型

  • 遺傳毒性測試
  • 致癌性試驗
  • 發育/生殖毒性測試
  • 其他考試類型

第7章全球毒理學測試市場：依方法

  • 生化測試
  • 血液學檢查
  • 病理檢查

第8章全球毒理學測試市場：依技術分類

  • 體內測試
  • 體外試驗

第9章全球毒理學測試市場：依最終用戶分類

  • 食品工業
  • 製藥和生物技術公司
  • 化妝品及個人護理行業
  • 學術研究所
  • 其他最終用戶

第10章全球毒理學測試市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第11章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第12章 公司簡介

  • Abbott Laboratories
  • Eurofins Scientific
  • Laboratory Corporation Of America Holdings
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Agilent Technolgies, Inc.
  • Catalent, Inc.
  • Bio-Rad Laboratories, Inc.
  • Bioivt
  • Gentronix
Product Code: SMRC24561

According to Stratistics MRC, the Global Toxicology Testing Market is growing at a CAGR of 15.9% during the forecast period. Toxicology testing involves evaluating the effects of substances on living organisms to assess potential hazards to human health and the environment. It determines the safety, toxicity, and risks associated with chemicals, pharmaceuticals, consumer products, and environmental pollutants. Its importance lies in safeguarding public health by identifying and mitigating risks, aiding regulatory compliance, and guiding product development.

According to NCBI, for every 10,000 compounds synthesized in the discovery phase, only 250 reach the preclinical phase, ultimately resulting in one approved drug by the FDA.

Market Dynamics:

Driver:

Increasing R&D activities

Industries such as pharmaceuticals, biotechnology, and chemical manufacturing are continually exploring novel compounds, formulations, and products. Toxicology testing plays a pivotal role in these sectors by evaluating the safety, efficacy, and potential risks of these innovations before market introduction. Moreover, robust toxicological assessments ensure compliance with regulatory standards and help mitigate adverse effects on human health and the environment. The need for thorough toxicological testing is growing as R&D efforts to address changing consumer demands and technological breakthroughs rise, making it an essential step in the creation and approval of novel medications, chemicals, and products.

Restraint:

Complexity in data interpretation

The complex and varied data produced by many experiments and cutting-edge technologies presents analytical difficulties that make it difficult to analyze and translate into useful insights. Accurate assessment of this complexity necessitates specific knowledge, advanced instruments, and standardized frameworks. Errors or uncertainty when interpreting these complex statistics can impair decision-making in risk assessments, regulatory filings, and product development, thereby impeding market approvals and developments.

Opportunity:

Growing demand for alternative testing methods

Advanced technologies such as in vitro assays, organoids, microfluidics systems, and computational models offer promising alternatives for toxicology assessments, providing more accurate, cost-effective, and ethical testing avenues. Companies investing in research and development to validate and commercialize these alternative methods stand to capitalize on this growing demand. Moreover, the widespread adoption of these alternatives also streamlines testing processes, fosters quicker results, and aligns with the global trend towards more humane and predictive toxicology evaluations. Thus, there is propelling market expansion.

Threat:

Regulatory changes

Evolving and stringent regulations governing safety assessments necessitate continuous adaptation and compliance, impacting testing methodologies, validation requirements, and timelines for product approvals. Sudden shifts in regulatory standards or the introduction of new guidelines may lead to uncertainties, increased costs, and delays in the approval process. Failure to promptly align with new standards could result in non-compliance penalties, reduced competitiveness, and impediments to market access, posing challenges for companies in maintaining efficiency and meeting evolving requirements within the toxicology testing market.

COVID-19 Impact

The COVID-19 outbreak initially affected operations and research due to lockdowns and redirected resources towards pandemic-related studies. Delays in trials and regulatory processes ensued, slowing down product approvals. However, the crisis highlighted the criticality of toxicology testing in vaccine development and drug safety assessments, elevating its importance. The industry adapted with remote work and virtual trials, fostering innovation and digitalization. Increased awareness of safety evaluations resulted in a renewed emphasis on robust testing methodologies, paving the way for a resilient recovery post-pandemic.

The genetic toxicology testing segment is expected to be the largest during the forecast period

The genetic toxicology testing segment is estimated to hold the largest share. Genetic toxicology testing employs assays to evaluate a substance's ability to induce mutations, chromosomal aberrations, or DNA damage, which is crucial in identifying potential carcinogens or harmful compounds. These tests encompass in vitro and in vivo methods, such as the Ames test, micronucleus assay, and comet assay, to comprehensively analyze genotoxicity. Moreover, understanding genetic toxicity aids in determining the safety of pharmaceuticals, chemicals, pesticides, and consumer products, contributing significantly to regulatory evaluations, and ensuring the protection of human health and the environment from harmful genetic alterations.

The in-vivo testing segment is expected to have the highest CAGR during the forecast period

The in-vivo testing segment is anticipated to have lucrative growth during the forecast period. In vivo tests refer to a type of experiment that is carried out within a whole, living organism, such as a plant or animal. It helps to determine toxicity levels, adverse reactions, and potential health hazards, providing crucial data for regulatory assessments and safety evaluations. Moreover, these tests, despite ethical considerations, remain essential for comprehensively understanding the biological effects of substances and ensuring the protection of human health and the environment from potentially harmful compounds.

Region with largest share:

Asia Pacific commanded the largest market share during the extrapolated period owing to increasing industrialization, stringent regulatory guidelines, and rising awareness regarding environmental safety. Advancements in technology and expanding pharmaceutical and biotechnology sectors, coupled with the demand for toxicological evaluations in the cosmetics and food industries, drive market expansion. Moreover, countries like China, India, Japan, and South Korea are pivotal contributors due to their expanding economies and growing research initiatives. This market's growth is fuelled by the emphasis on product safety assessment and the need for reliable toxicology testing methods.

Region with highest CAGR:

North America is expected to witness profitable growth over the projection period, due to stringent regulatory frameworks, heightened focus on product safety, and technological advancements. The region's well-established pharmaceutical and biotechnology industries, along with increased R&D activities, propel market expansion. Moreover, rising concerns about chemical exposure, coupled with the need for efficient toxicological evaluations in various sectors, including healthcare, cosmetics, and environmental monitoring, are driving market growth. Key contributors like the United States and Canada witness continual advancements in testing methodologies, fostering innovation and market penetration.

Key players in the market:

Some of the key players in the Toxicology Testing Market include Abbott Laboratories, Eurofins Scientific, Laboratory Corporation Of America Holdings, Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technolgies, Inc., Catalent, Inc., Bio-Rad Laboratories, Inc., Bioivt and Gentronix.

Key Developments:

In November 2023, Thermo Fisher Scientific & Flagship Pioneering Expand Ongoing Strategic Partnership to Jointly Create New Platform Companies with First-in-Class Enabling Technologies for Life Sciences.

In October 2023, Thermo Fisher Scientific, the world leader in serving science, has introduced the Thermo Scientific™ Meridian™ EX System- an electron-beam-based failure analysis solution designed to enable precise fault localization on advanced semiconductor logic technologies.

In September 2023, Thermo Fisher Scientific and National Minority Quality Forum Collaborate to support biopharmaceutical and biotech customers in meeting regulatory expectations to enroll and retain patients in clinical trials who more fully reflect real-world populations experiencing the disease or health condition being studied, including U.S. Food and Drug Administration requirements around diversity action plans.

Products Covered:

  • Instruments
  • Reagents and Kits
  • Other Products

Test Types Covered:

  • Genetic Toxicology Testing
  • Carcinogenicity Testing
  • Developmental and Reproductive Toxicology Testing
  • Other Test Types

Methods Covered:

  • Biochemical Testing
  • Hematology Testing
  • Pathology Testing

Technologies Covered:

  • In-vivo Testing
  • In-vitro Testing

End Users Covered:

  • Food and Beverage Industry
  • Pharmaceutical and Biotechnology Companies
  • Cosmetics and Personal Care Industry
  • Academic and Research Institutions
  • Other End Users

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Technology Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Toxicology Testing Market, By Product

  • 5.1 Introduction
  • 5.2 Instruments
  • 5.3 Reagents and Kits
  • 5.4 Other Products

6 Global Toxicology Testing Market, By Test Type

  • 6.1 Introduction
  • 6.2 Genetic Toxicology Testing
  • 6.3 Carcinogenicity Testing
  • 6.4 Developmental and Reproductive Toxicology Testing
  • 6.5 Other Test Types

7 Global Toxicology Testing Market, By Method

  • 7.1 Introduction
  • 7.2 Biochemical Testing
  • 7.3 Hematology Testing
  • 7.4 Pathology Testing

8 Global Toxicology Testing Market, By Technology

  • 8.1 Introduction
  • 8.2 In-vivo Testing
  • 8.3 In-vitro Testing

9 Global Toxicology Testing Market, By End User

  • 9.1 Introduction
  • 9.2 Food and Beverage Industry
  • 9.3 Pharmaceutical and Biotechnology Companies
  • 9.4 Cosmetics and Personal Care Industry
  • 9.5 Academic and Research Institutions
  • 9.6 Other End Users

10 Global Toxicology Testing Market, By Geography

  • 10.1 Introduction
  • 10.2 North America
    • 10.2.1 US
    • 10.2.2 Canada
    • 10.2.3 Mexico
  • 10.3 Europe
    • 10.3.1 Germany
    • 10.3.2 UK
    • 10.3.3 Italy
    • 10.3.4 France
    • 10.3.5 Spain
    • 10.3.6 Rest of Europe
  • 10.4 Asia Pacific
    • 10.4.1 Japan
    • 10.4.2 China
    • 10.4.3 India
    • 10.4.4 Australia
    • 10.4.5 New Zealand
    • 10.4.6 South Korea
    • 10.4.7 Rest of Asia Pacific
  • 10.5 South America
    • 10.5.1 Argentina
    • 10.5.2 Brazil
    • 10.5.3 Chile
    • 10.5.4 Rest of South America
  • 10.6 Middle East & Africa
    • 10.6.1 Saudi Arabia
    • 10.6.2 UAE
    • 10.6.3 Qatar
    • 10.6.4 South Africa
    • 10.6.5 Rest of Middle East & Africa

11 Key Developments

  • 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 11.2 Acquisitions & Mergers
  • 11.3 New Product Launch
  • 11.4 Expansions
  • 11.5 Other Key Strategies

12 Company Profiling

  • 12.1 Abbott Laboratories
  • 12.2 Eurofins Scientific
  • 12.3 Laboratory Corporation Of America Holdings
  • 12.4 Thermo Fisher Scientific, Inc.
  • 12.5 Danaher Corporation
  • 12.6 Agilent Technolgies, Inc.
  • 12.7 Catalent, Inc.
  • 12.8 Bio-Rad Laboratories, Inc.
  • 12.9 Bioivt
  • 12.10 Gentronix

List of Tables

  • Table 1 Global Toxicology Testing Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 3 Global Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 4 Global Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 5 Global Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 6 Global Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 7 Global Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 8 Global Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 9 Global Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 10 Global Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 11 Global Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 12 Global Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 13 Global Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 14 Global Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 15 Global Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 16 Global Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 17 Global Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 18 Global Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 19 Global Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 20 Global Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 21 Global Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 22 Global Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 23 Global Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 24 North America Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 25 North America Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 26 North America Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 27 North America Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 28 North America Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 29 North America Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 30 North America Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 31 North America Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 32 North America Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 33 North America Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 34 North America Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 35 North America Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 36 North America Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 37 North America Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 38 North America Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 39 North America Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 40 North America Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 41 North America Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 42 North America Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 43 North America Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 44 North America Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 45 North America Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 46 North America Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 47 Europe Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 48 Europe Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 49 Europe Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 50 Europe Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 51 Europe Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 52 Europe Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 53 Europe Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 54 Europe Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 55 Europe Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 56 Europe Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 57 Europe Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 58 Europe Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 59 Europe Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 60 Europe Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 61 Europe Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 62 Europe Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 63 Europe Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 64 Europe Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 65 Europe Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 66 Europe Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 67 Europe Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 68 Europe Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 69 Europe Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 70 Asia Pacific Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 71 Asia Pacific Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 72 Asia Pacific Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 73 Asia Pacific Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 74 Asia Pacific Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 75 Asia Pacific Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 76 Asia Pacific Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 77 Asia Pacific Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 78 Asia Pacific Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 79 Asia Pacific Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 80 Asia Pacific Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 81 Asia Pacific Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 82 Asia Pacific Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 83 Asia Pacific Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 84 Asia Pacific Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 85 Asia Pacific Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 86 Asia Pacific Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 87 Asia Pacific Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 88 Asia Pacific Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 89 Asia Pacific Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 90 Asia Pacific Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 91 Asia Pacific Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 92 Asia Pacific Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 93 South America Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 94 South America Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 95 South America Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 96 South America Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 97 South America Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 98 South America Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 99 South America Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 100 South America Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 101 South America Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 102 South America Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 103 South America Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 104 South America Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 105 South America Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 106 South America Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 107 South America Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 108 South America Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 109 South America Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 110 South America Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 111 South America Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 112 South America Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 113 South America Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 114 South America Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 115 South America Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)
  • Table 116 Middle East & Africa Toxicology Testing Market Outlook, By Country (2021-2030) ($MN)
  • Table 117 Middle East & Africa Toxicology Testing Market Outlook, By Product (2021-2030) ($MN)
  • Table 118 Middle East & Africa Toxicology Testing Market Outlook, By Instruments (2021-2030) ($MN)
  • Table 119 Middle East & Africa Toxicology Testing Market Outlook, By Reagents and Kits (2021-2030) ($MN)
  • Table 120 Middle East & Africa Toxicology Testing Market Outlook, By Other Products (2021-2030) ($MN)
  • Table 121 Middle East & Africa Toxicology Testing Market Outlook, By Test Type (2021-2030) ($MN)
  • Table 122 Middle East & Africa Toxicology Testing Market Outlook, By Genetic Toxicology Testing (2021-2030) ($MN)
  • Table 123 Middle East & Africa Toxicology Testing Market Outlook, By Carcinogenicity Testing (2021-2030) ($MN)
  • Table 124 Middle East & Africa Toxicology Testing Market Outlook, By Developmental and Reproductive Toxicology Testing (2021-2030) ($MN)
  • Table 125 Middle East & Africa Toxicology Testing Market Outlook, By Other Test Types (2021-2030) ($MN)
  • Table 126 Middle East & Africa Toxicology Testing Market Outlook, By Method (2021-2030) ($MN)
  • Table 127 Middle East & Africa Toxicology Testing Market Outlook, By Biochemical Testing (2021-2030) ($MN)
  • Table 128 Middle East & Africa Toxicology Testing Market Outlook, By Hematology Testing (2021-2030) ($MN)
  • Table 129 Middle East & Africa Toxicology Testing Market Outlook, By Pathology Testing (2021-2030) ($MN)
  • Table 130 Middle East & Africa Toxicology Testing Market Outlook, By Technology (2021-2030) ($MN)
  • Table 131 Middle East & Africa Toxicology Testing Market Outlook, By In-vivo Testing (2021-2030) ($MN)
  • Table 132 Middle East & Africa Toxicology Testing Market Outlook, By In-vitro Testing (2021-2030) ($MN)
  • Table 133 Middle East & Africa Toxicology Testing Market Outlook, By End User (2021-2030) ($MN)
  • Table 134 Middle East & Africa Toxicology Testing Market Outlook, By Food and Beverage Industry (2021-2030) ($MN)
  • Table 135 Middle East & Africa Toxicology Testing Market Outlook, By Pharmaceutical and Biotechnology Companies (2021-2030) ($MN)
  • Table 136 Middle East & Africa Toxicology Testing Market Outlook, By Cosmetics and Personal Care Industry (2021-2030) ($MN)
  • Table 137 Middle East & Africa Toxicology Testing Market Outlook, By Academic and Research Institutions (2021-2030) ($MN)
  • Table 138 Middle East & Africa Toxicology Testing Market Outlook, By Other End Users (2021-2030) ($MN)